Portland, OR -- (SBWire) -- 02/22/2018 --The major players in the syphilis testing market space are focusing on technological advancements, product & service innovation in order to retain their position in the market. Major companies profiled in the report include Roche Diagnostics, Hologic, Inc.,Becton Dickinson& Company, Abbott Laboratories, BioMerieux, Alere Inc., Cepheid Inc., Affymetrix, Inc. and Diasorin.
Get PDF Brochure For Details: https://www.alliedmarketresearch.com/request-sample/675
Syphilis continues to be a global health concern due to the increasing incidences occurring mainly among bisexuals and gay people. According to the World Health Organization (WHO), there were an estimated 36 million cases of syphilis in 2013 globally, with over 11 million new cases occurring annually. Additionally, around 90% of the syphilis cases are prevalent in developing countries with similar trends now observed in developed nations as well. The increasing syphilis cases are mainly due to the growing rate of anonymous sex, sex with multiple partners, sex under the influence of several drugs and increasing number of unprotected sex both anal and oral. Moreover, this is also gaining prominence in pregnant women due to the sex with infected partners, which can further lead to congenital abnormalities such as stillbirth, abortions and other abnormalities in pregnancy.
Syphilis Testing Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the period 2014-2020. The secondary syphilis testing would continue to be the largest market segment through 2020.Latin America,Middle East&Africa(LAMEA) market accounted for about 43% revenue share of the syphilis testing market in 2014.
Enquiry About Report: https://www.alliedmarketresearch.com/purchase-enquiry/675
Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results - thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.
Syphilis Testing Market Key Market Segments
The global market is segmented into types and geography.
By Types -
Primary Syphilis
Secondary Syphilis
By Geography -
North America
United States
Canada
Mexico
Connect to analyst: https://www.alliedmarketresearch.com/connect-to-analyst/675
Worldwide Syphilis Testing Market: Introduction, Market Landscape Up to 2020
Syphilis Testing Market is Expected to Reach $3.6 Billion, Globally, by 2020